ArticleSmall methods2025
Autonomous Bayesian Optimization-Based Control System for Droplet Generation.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Engineered Neutrophils in Translational Medicine: Gene Editing, Nanotechnology, and AI-Driven Clinical Breakthroughs.Advanced healthcare materials · 2026Review
- Autonomous Bayesian Optimization-Based Control System for Droplet Generation.Small methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Droplet generation has been utilized in various applications, including drug delivery, the fabrication of functional particles, and material synthesis. Achieving the goals of these applications requires droplet generation of a desired size. Microfluidic droplet generation offers precise control of droplet dimensions. However, the flow rates of the droplet and medium phases depend on the channel configuration and properties of the working fluids, and their optimization is a labor-intensive and time-consuming process. To overcome these limitations, an autonomous Bayesian optimization (BO)-based control system for droplet generation (ABCD) is developed. In ABCD, BO is employed to inform decision-making and refine the experimental conditions. Additionally, computer vision techniques, including image processing and convolutional neural networks, are utilized to analyze the experimental results and provide a dataset for use in decision-making. The ABCD identified the optimal flow rates to achieve desired droplet sizes and generation frequencies via precise and efficient searches, regardless of the droplet generation target, working fluids, channel geometry, and droplet morphology, within 15 iterations on average. It is anticipated that this system will contribute to the acceleration of research utilizing droplet-based microfluidic systems while also extending microfluidic process automation in various industrial applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.